The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pet Anthelmintic Drugs Market Research Report 2024

Global Pet Anthelmintic Drugs Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1806538

No of Pages : 101

Ask Your Query

Global Pet Anthelmintic Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Anthelmintic Drugs market research.

Key companies engaged in the Pet Anthelmintic Drugs industry include Elanco, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Group, Dechra, Durvet, First Priority, Jeffers and Manna Pro Products, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Pet Anthelmintic Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pet Anthelmintic Drugs market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pet Anthelmintic Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List):

  •     Elanco
  •     Boehringer Ingelheim
  •     Ceva Sante Animale
  •     Chanelle Group
  •     Dechra
  •     Durvet
  •     First Priority
  •     Jeffers
  •     Manna Pro Products
  •     Merck Animal Health
  •     Ourofino
  •     TTK Healthcare
  •     Vetoquinol
  •     Virbac
  •     Zoetis

Segment by Type

  •     External
  •     Internal
  •     Composite
  •     Injection

Segment by Application

  •     Dog
  •     Cat
  •     Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

The Pet Anthelmintic Drugs report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 External
        1.2.3 Internal
        1.2.4 Composite
        1.2.5 Injection
    1.3 Market by Application
        1.3.1 Global Pet Anthelmintic Drugs Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Pet Anthelmintic Drugs Market Perspective (2018-2029)
    2.2 Pet Anthelmintic Drugs Growth Trends by Region
        2.2.1 Global Pet Anthelmintic Drugs Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Pet Anthelmintic Drugs Historic Market Size by Region (2018-2023)
        2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Region (2024-2029)
    2.3 Pet Anthelmintic Drugs Market Dynamics
        2.3.1 Pet Anthelmintic Drugs Industry Trends
        2.3.2 Pet Anthelmintic Drugs Market Drivers
        2.3.3 Pet Anthelmintic Drugs Market Challenges
        2.3.4 Pet Anthelmintic Drugs Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
        3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2018-2023)
        3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2018-2023)
    3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
    3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
        3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2022
    3.5 Pet Anthelmintic Drugs Key Players Head office and Area Served
    3.6 Key Players Pet Anthelmintic Drugs Product Solution and Service
    3.7 Date of Enter into Pet Anthelmintic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Pet Anthelmintic Drugs Breakdown Data by Type
    4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2018-2023)
    4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2024-2029)

 5 Pet Anthelmintic Drugs Breakdown Data by Application
    5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2018-2023)
    5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Pet Anthelmintic Drugs Market Size (2018-2029)
    6.2 North America Pet Anthelmintic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Pet Anthelmintic Drugs Market Size by Country (2018-2023)
    6.4 North America Pet Anthelmintic Drugs Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Pet Anthelmintic Drugs Market Size (2018-2029)
    7.2 Europe Pet Anthelmintic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Pet Anthelmintic Drugs Market Size by Country (2018-2023)
    7.4 Europe Pet Anthelmintic Drugs Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2018-2029)
    8.2 Asia-Pacific Pet Anthelmintic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2018-2023)
    8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Pet Anthelmintic Drugs Market Size (2018-2029)
    9.2 Latin America Pet Anthelmintic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Pet Anthelmintic Drugs Market Size by Country (2018-2023)
    9.4 Latin America Pet Anthelmintic Drugs Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2018-2029)
    10.2 Middle East & Africa Pet Anthelmintic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2018-2023)
    10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Elanco
        11.1.1 Elanco Company Detail
        11.1.2 Elanco Business Overview
        11.1.3 Elanco Pet Anthelmintic Drugs Introduction
        11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.1.5 Elanco Recent Development
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Detail
        11.2.2 Boehringer Ingelheim Business Overview
        11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
        11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.2.5 Boehringer Ingelheim Recent Development
    11.3 Ceva Sante Animale
        11.3.1 Ceva Sante Animale Company Detail
        11.3.2 Ceva Sante Animale Business Overview
        11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
        11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.3.5 Ceva Sante Animale Recent Development
    11.4 Chanelle Group
        11.4.1 Chanelle Group Company Detail
        11.4.2 Chanelle Group Business Overview
        11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
        11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.4.5 Chanelle Group Recent Development
    11.5 Dechra
        11.5.1 Dechra Company Detail
        11.5.2 Dechra Business Overview
        11.5.3 Dechra Pet Anthelmintic Drugs Introduction
        11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.5.5 Dechra Recent Development
    11.6 Durvet
        11.6.1 Durvet Company Detail
        11.6.2 Durvet Business Overview
        11.6.3 Durvet Pet Anthelmintic Drugs Introduction
        11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.6.5 Durvet Recent Development
    11.7 First Priority
        11.7.1 First Priority Company Detail
        11.7.2 First Priority Business Overview
        11.7.3 First Priority Pet Anthelmintic Drugs Introduction
        11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.7.5 First Priority Recent Development
    11.8 Jeffers
        11.8.1 Jeffers Company Detail
        11.8.2 Jeffers Business Overview
        11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
        11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.8.5 Jeffers Recent Development
    11.9 Manna Pro Products
        11.9.1 Manna Pro Products Company Detail
        11.9.2 Manna Pro Products Business Overview
        11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
        11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.9.5 Manna Pro Products Recent Development
    11.10 Merck Animal Health
        11.10.1 Merck Animal Health Company Detail
        11.10.2 Merck Animal Health Business Overview
        11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
        11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.10.5 Merck Animal Health Recent Development
    11.11 Ourofino
        11.11.1 Ourofino Company Detail
        11.11.2 Ourofino Business Overview
        11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
        11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.11.5 Ourofino Recent Development
    11.12 TTK Healthcare
        11.12.1 TTK Healthcare Company Detail
        11.12.2 TTK Healthcare Business Overview
        11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
        11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.12.5 TTK Healthcare Recent Development
    11.13 Vetoquinol
        11.13.1 Vetoquinol Company Detail
        11.13.2 Vetoquinol Business Overview
        11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
        11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.13.5 Vetoquinol Recent Development
    11.14 Virbac
        11.14.1 Virbac Company Detail
        11.14.2 Virbac Business Overview
        11.14.3 Virbac Pet Anthelmintic Drugs Introduction
        11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.14.5 Virbac Recent Development
    11.15 Zoetis
        11.15.1 Zoetis Company Detail
        11.15.2 Zoetis Business Overview
        11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
        11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2018-2023)
        11.15.5 Zoetis Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock